Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice
- PMID: 19150478
- DOI: 10.1016/j.pnpbp.2008.12.010
Phenotype of spontaneous orofacial dyskinesia in neuregulin-1 'knockout' mice
Abstract
Studies in antipsychotic-naïve patients with schizophrenia indicate a baseline level of spontaneous involuntary movements, particularly orofacial dyskinesia. Neuregulin-1 is associated with risk for schizophrenia and its functional role can be studied in 'knockout' mice. We have shown previously that neuregulin-1 'knockouts' evidence disruption in social behaviour. Neuregulin-1 'knockouts' were assessed for four topographies of orofacial movement, both spontaneously and under challenge with the D(1)-like dopamine receptor agonist SKF 83959. Neuregulin-1 'knockouts' evidenced an increase in spontaneous incisor chattering, particularly among males. SKF 83959 induced incisor chattering, vertical jaw movements and tongue protrusions; the level of horizontal jaw movements was increased and that of tongue protrusions decreased in neuregulin-1 'knockouts'. These findings indicate that the schizophrenia risk gene neuregulin-1 is involved in the regulation of not only social behaviour but also orofacial dyskinesia. Orofacial dyskinesia in neuregulin-1 mutants may indicate some modest genetic relationship between risk for schizophrenia and vulnerability to spontaneous movement disorder.
Similar articles
-
Comparative phenotypic resolution of spontaneous, D2-like and D1-like agonist-induced orofacial movement topographies in congenic mutants with dopamine D2 vs. D3 receptor "knockout".Synapse. 2004 Jan;51(1):71-81. doi: 10.1002/syn.10284. Synapse. 2004. PMID: 14579426
-
Phenotypic characterization of orofacial movement topography in mutants with disruption of amino acid mechanisms: glutamate N2A/B/D [GluRε1/2/4] subtypes and the GABA synthesizing enzyme GAD65.Neuroscience. 2013 Oct 10;250:743-54. doi: 10.1016/j.neuroscience.2013.07.038. Epub 2013 Jul 25. Neuroscience. 2013. PMID: 23892010
-
Orofacial movements in phospholipase C-related catalytically inactive protein-1/2 double knockout mice: Effect of the GABAergic agent diazepam and the D(1) dopamine receptor agonist SKF 83959.Synapse. 2010 Sep;64(9):714-20. doi: 10.1002/syn.20798. Synapse. 2010. PMID: 20340178
-
Regulation of orofacial movement: dopamine receptor mechanisms and mutant models.Int Rev Neurobiol. 2011;97:39-60. doi: 10.1016/B978-0-12-385198-7.00002-3. Int Rev Neurobiol. 2011. PMID: 21708306 Review.
-
Constitutive and conditional mutant mouse models for understanding dopaminergic regulation of orofacial movements: emerging insights and challenges.J Pharmacol Sci. 2012;119(4):297-301. doi: 10.1254/jphs.12r05cp. Epub 2012 Jul 21. J Pharmacol Sci. 2012. PMID: 22863668 Review.
Cited by
-
ErbB inhibitors ameliorate behavioral impairments of an animal model for schizophrenia: implication of their dopamine-modulatory actions.Transl Psychiatry. 2013 Apr 30;3(4):e252. doi: 10.1038/tp.2013.29. Transl Psychiatry. 2013. PMID: 23632456 Free PMC article.
-
Peering into the mind: unraveling schizophrenia's secrets using models.Mol Psychiatry. 2025 Feb;30(2):659-678. doi: 10.1038/s41380-024-02728-w. Epub 2024 Sep 8. Mol Psychiatry. 2025. PMID: 39245692 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases